A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade
Clinical trial NCT04124094 · COMPLETED
Trial details
- NCT number
- NCT04124094
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2019-10-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.